neobookRx
DrugsLevel 4 LocalisationS4INJEML

Varicella-Zoster Vaccine (Zoster, Live Attenuated)

Varicella-Zoster vaccineViral vaccine

Indications

Registered South African indications:

  • Immunisation against herpes zoster
  • Prevention of post-herpetic neuralgia

Cautions

Contraindications

  • Hypersensitivity to the active ingredient or any of its excipients
  • Hypersensitivity to neomycin
  • Pregnancy
  • Primary and acquired immunodeficiency states due to conditions such as
    - Acute and chronic leukaemia's
    - Lymphoma
    - Other conditions affecting the bone marrow or lymphatic system
    - Immunosuppression due to HIV/AIDS
    - Cellular immune deficiencies
  • Immunosuppressive therapy (including high-dose corticosteroids); however, varicella-zoster vaccine is not contraindicated for use in individuals who are receiving topical/inhaled corticosteroids or low-dose systemic corticosteroids or in patients who are receiving corticosteroids as replacement therapy, e.g., for adrenal insufficiency
  • Active, untreated tuberculosis

Cautions

  • Breastfeeding
  • Severe thrombocytopenia 
  • Coagulation disorder
  • Moderate to severe acute febrile illness or infection

Adult dosage

Forms avail. in SA and covered in this monograph: inj

Prevention of herpes zoster
- For immunization of individuals older than 50 years
Prevention of herpes zoster-related post-herpetic neuralgia
- For immunization of individuals older than 50 years

  • SC: 0.65ml, as a single dose

Paediatric dosage

Not established for use in children

Special populations

Pregnancy

  • Contraindicated

Breastfeeding

Renal Impairment

Hepatic Impairment

Elderly

Adverse reactions

Central Nervous System Disorders

  • Headache

Gastrointestinal Disorders

  • Nausea

Musculoskeletal Disorders

  • Arthralgia
  • Myalgia
  • Pain in extremity

Skin and Subcutaneous Tissue Disorders

  • Varicella 
  • Herpes zoster
  • Rash
  • Injection site reactions

Immune, Blood and Lymphatic System Disorders

  • Lymphadenopathy
  • Hypersensitivity reactions
  • Anaphylaxis

Sensory Disorders

  • Necrotizing retinitis

Interactions

  • Pneumococcal polysaccharide vaccine
  • Antiviral agents

Monitoring

None routine

Mechanism of action

The live, attentuated varicella-zoster vaccine stimulates the production of antibodies to the varicella-zoster virus.

Dosage forms

  • Injection

Formulation

Injection (per 0.65ml) 19400pfu

  • Zostavax (MSD) originator

References

1. SAMF_12th Edition_Page 368 2. https://www.medicines.org.uk/emc/medicine/25927 (01/03/2017_Merck_Zostavax_inj) 3. https://drive.google.com/drive/folders/0B27NqM_vidrmT0hoMjVvM20ydzg (06/08/2015_MSD_Zostavax_inj) 4. https://www.uptodate.com/contents/zoster-vaccine-drug-information?source=preview&search=herpes%20zoster%20vaccine&anchor=F2985447#F2985447 5. https://www.drugs.com/pregnancy/zoster-vaccine-live.html

Brands & products

1 product · cached snapshot
Trade names (1)
  • Zostavax

INJInjection· 1 product

from R2094.36
ProductStrengthPackApplicantMin price
Zostavax19400 pfu/0.65ml0.65MSD (Pty) LtdR2094.36

Medical aid coverage

data not yet integrated
Discovery Health
not yet integrated
  • Comprehensive Series—
  • Executive Plan—
  • KeyCare Series—
  • Priority Series—
  • Saver Series—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

Bonitas Medical Fund
not yet integrated
  • BonClassic—
  • BonComprehensive—
  • BonEssential—
  • BonFit Select—
  • BonSave—
  • BonStart—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

GEMS — Government Employees Medical Scheme
not yet integrated
  • Beryl—
  • Emerald—
  • Onyx—
  • Ruby—
  • Sapphire—
  • Tanzanite One—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

POLMED — Police Medical Aid Scheme
not yet integrated
  • Aquarium Option—
  • Efficiency Option—
  • Marine Option—

Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.

NeoHealth® ID 15221 · updated 1/15/2025